A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity
NCT07731139
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Placebo
DRUG:
PF-08642534
Sponsor
Pfizer